| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1049554402 |
| P356 | DOI | 10.1186/AR1009 |
| P932 | PMC publication ID | 2833441 |
| P698 | PubMed publication ID | 15180894 |
| P5875 | ResearchGate publication ID | 8525818 |
| P2093 | author name string | Peter E Lipsky | |
| Amrie C Grammer | |||
| P2860 | cites work | TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease | Q22254041 |
| Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins | Q73160694 | ||
| Regulation of the T-independent humoral response by TACI | Q73923479 | ||
| Activation and accumulation of B cells in TACI-deficient mice | Q74108091 | ||
| The AIDS disease of CD4C/HIV transgenic mice shows impaired germinal centers and autoantibodies and develops in the absence of IFN-gamma and IL-6 | Q74419730 | ||
| Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity | Q74433998 | ||
| Inflamed kidneys of NZB / W mice are a major site for the homeostasis of plasma cells | Q74460576 | ||
| Altered selection processes of B lymphocytes in autoimmune NZB/W mice, despite intact central tolerance against DNA | Q74460601 | ||
| Immunology. Autoreactive B cells migrate into T cell territory | Q74813249 | ||
| Cutting Edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease | Q77373855 | ||
| Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells | Q77514534 | ||
| APRIL modulates B and T cell immunity | Q24552299 | ||
| BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF | Q28213294 | ||
| Human follicular dendritic cells: function, origin and development | Q28216978 | ||
| Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees | Q28776419 | ||
| Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus | Q33928629 | ||
| Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. | Q33947934 | ||
| Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. | Q33951524 | ||
| CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. | Q34082784 | ||
| Comparative characteristics of mu chain and alpha chain transcripts expressed by individual tonsil plasma cells. | Q34085624 | ||
| Autoimmune diseases. | Q34325674 | ||
| Ectopic lymphoid organogenesis: a fast track for autoimmunity | Q34363840 | ||
| Delineating the genetic basis of systemic lupus erythematosus | Q34376876 | ||
| Plasma cells: finding new light at the end of B cell development | Q34450168 | ||
| Immunoglobulin variable-region gene usage in systemic autoimmune diseases | Q34474688 | ||
| The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus | Q34525244 | ||
| Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice | Q35110335 | ||
| BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. | Q35140484 | ||
| Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. | Q35231549 | ||
| Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response | Q36368953 | ||
| Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations | Q36375661 | ||
| Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle | Q36380737 | ||
| Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. | Q36991109 | ||
| Circulating and mitogen-induced immunoglobulin-secreting cells in human peripheral blood: evaluation by a modified reverse hemolytic plaque assay | Q40859333 | ||
| The CD40 ligand expressed by human B cells costimulates B cell responses | Q41345776 | ||
| Unique site of IgG2a and rheumatoid factor production in MRL/lpr mice | Q41492243 | ||
| Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells | Q42942148 | ||
| Cyclophosphamide use in a young woman with antiphospholipid antibodies and recurrent cerebrovascular accident. | Q44523327 | ||
| Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus | Q44839857 | ||
| Spontaneous formation of germinal centers in autoimmune mice. | Q47574161 | ||
| Expression, regulation, and function of B cell-expressed CD154 in germinal centers. | Q52031799 | ||
| Bcmd governs recruitment of new B cells into the stable peripheral B cell pool in the A/WySnJ mouse. | Q52047114 | ||
| Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. | Q52054451 | ||
| Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. | Q52114309 | ||
| Affinity maturation in ectopic germinal centers. | Q52968808 | ||
| Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. | Q54167674 | ||
| An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway | Q57230082 | ||
| Generation of nondividing high rate Ig-secreting plasma cells in cultures of human B cells stimulated with anti-CD3-activated T cells | Q68052233 | ||
| Independent expression of autoantibodies in systemic lupus erythematosus | Q72119151 | ||
| The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man | Q72698516 | ||
| CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice: phenotype and possible role in autoreactivity | Q73084836 | ||
| A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis | Q73114791 | ||
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| B-cell | Q188930 | ||
| P304 | page(s) | S22-7 | |
| P577 | publication date | 2003-12-02 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | B cell abnormalities in systemic lupus erythematosus | |
| P478 | volume | 5 Suppl 4 |
| Q46197457 | 11th annual Inflammatory and Immune Diseases Drug Discovery and Development Summit 12-13 March 2007, San Francisco, USA. |
| Q84803684 | A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide |
| Q54465969 | A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis. |
| Q34404682 | Aberrant CD40-induced NF-κB activation in human lupus B lymphocytes |
| Q47365066 | Abnormal B-cell development in Systemic Lupus Erythematosus: what the genetics tell us. |
| Q44985029 | Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation |
| Q28386271 | Antigen-specific human NKT cells from tuberculosis patients produce IL-21 to help B cells for the production of immunoglobulins |
| Q92987312 | B cell checkpoints in autoimmune rheumatic diseases |
| Q34009020 | B cell signature during inactive systemic lupus is heterogeneous: toward a biological dissection of lupus |
| Q44699204 | B-cell biology and related therapies in systemic lupus erythematosus |
| Q42603286 | B-cell-targeted therapy for systemic lupus erythematosus |
| Q36229560 | BAFF and MyD88 signals promote a lupuslike disease independent of T cells |
| Q36088054 | BLyS antagonists and peptide tolerance induction |
| Q35968394 | Challenges in bringing the bench to bedside in drug development for SLE. |
| Q92239600 | Complement Factor H Modulates Splenic B Cell Development and Limits Autoantibody Production |
| Q36863105 | Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells |
| Q38855495 | Current and Emerging Therapies for Lupus Nephritis |
| Q86553655 | Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation |
| Q29417087 | Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. |
| Q34015403 | Germinal center B cell depletion diminishes CD4+ follicular T helper cells in autoimmune mice |
| Q36338516 | HDAC expression and activity is upregulated in diseased lupus-prone mice |
| Q38060570 | How important is vitamin D in preventing infections? |
| Q36340132 | Human embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB/W F1 mouse model of lupus nephritis |
| Q35565080 | Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice. |
| Q34190173 | Increased levels of prolactin receptor expression correlate with the early onset of lupus symptoms and increased numbers of transitional-1 B cells after prolactin treatment |
| Q35536652 | Infection of Female BWF1 Lupus Mice with Malaria Parasite Attenuates B Cell Autoreactivity by Modulating the CXCL12/CXCR4 Axis and Its Downstream Signals PI3K/AKT, NFκB and ERK. |
| Q64121750 | Inhibition of IL-17 ameliorates systemic lupus erythematosus in Roquin mice through regulating the balance of TFH cells, GC B cells, Treg and Breg |
| Q42964283 | Inhibition of a C-rich oligodeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice |
| Q37812288 | Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus |
| Q37626256 | MicroRNA-let-7a promotes E2F-mediated cell proliferation and NFκB activation in vitro |
| Q34427053 | Molecular characterization of circulating plasma cells in patients with active systemic lupus erythematosus. |
| Q34702800 | Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival |
| Q37692210 | Off-label use of rituximab in systemic lupus erythematosus: a systematic review |
| Q35309470 | Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside |
| Q45938061 | Plasma cells in systemic lupus erythematosus: the long and short of it all. |
| Q36810295 | Possible therapeutic applications of single-chain antibodies in systemic autoimmune diseases. |
| Q51824324 | Raised expression of cytokine receptor gp130 subunit on peripheral lymphocytes of patients with active lupus. A useful tool for monitoring the disease activity? |
| Q33411406 | Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus |
| Q34350295 | Similarities and differences between selective and nonselective BAFF blockade in murine SLE |
| Q36019347 | T cells and B cells in lupus nephritis |
| Q89965638 | TRIM21 Dysfunction Enhances Aberrant B-Cell Differentiation in Autoimmune Pathogenesis |
| Q26746697 | Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway |
| Q37060593 | Targeting of the immune system in systemic lupus erythematosus |
| Q38672342 | The Active Metabolite of Vitamin D3 as a Potential Immunomodulator |
| Q29394347 | The pathogenesis of systemic lupus erythematosus—an update |
| Q33716669 | The role of B cells in lupus pathogenesis |
| Q37927252 | Vitamin D3: a helpful immuno-modulator |
Search more.